HRT Financial’s ClearPoint Neuro CLPT Stock Holding History

HRT Financial’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,947	Closed	-$423K	–	3905
2025 Q4	$423K	Buy	+30,947	New	+$574K	﹤0.01%	2195
2025 Q2	–	Sell	-72,775	Closed	-$865K	–	2740
2025 Q1	$865K	Buy	+72,775	New	+$1.13M	0.01%	1173
2024 Q3	–	Sell	-27,062	Closed	-$145K	–	2512
2024 Q2	$145K	Buy	+27,062	New	+$157K	﹤0.01%	1712
2023 Q2	–	Sell	-33,630	Closed	-$283K	–	2566
2023 Q1	$283K	Buy	+33,630	New	+$295K	﹤0.01%	1741
2021 Q2	–	Sell	-38,336	Closed	-$810K	–	2931
2021 Q1	$810K	Buy	+38,336	New	+$821K	0.01%	1338

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

HRT Financial's CLPT Position: Q1 2026 in Review

HRT Financial sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 30,947 shares — an estimated $423K sold.

HRT Financial first reported a position in CLPT in Q1 2021 and held it in 5 quarters. The position peaked at $865K in Q1 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

HRT Financial reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 30,947 ClearPoint Neuro shares in Q1 2026, an estimated $423K.
HRT Financial first reported a position in ClearPoint Neuro in Q1 2021 and held it in 5 quarters.
HRT Financial's ClearPoint Neuro position peaked at $865K in Q1 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.